Compositions comprising riboregulators and methods of use thereof

US11788156B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-11788156-B2
Application numberUS-202117477456-A
CountryUS
Kind codeB2
Filing dateSep 16, 2021
Priority dateJul 14, 2014
Publication dateOct 17, 2023
Grant dateOct 17, 2023

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

The invention provides novel and versatile classes of riboregulators, including inter alia activating and repressing riboregulators, switches, and trigger and sink RNA, and methods of their use for detecting RNAs in a sample such as a well and in modulating protein synthesis and expression.

First claim

Opening claim text (preview).

What is claimed is: 1. A method of controlling gene and/or protein expression in a cell comprising integrating or encoding a plurality of riboregulators into the genome of the cell, each riboregulator integrated upstream of a target coding sequence, modulating expression of one or more of plurality of trans-activating RNA (taRNA) in the cell, wherein expression of a taRNA in the cell results in increased expression of the target coding sequence, and wherein each riboregulator comprises an RNA comprising (i) a single-stranded toehold domain, (ii) a fully or partially double-stranded stem domain comprising an initiation codon, and (iii) a loop domain comprising a ribosome binding site, wherein each taRNA comprises (i) a first domain that hybridizes to the toehold domain of one of the riboregulators in the plurality and that comprises no or minimal secondary structure, and (ii) a second domain that hybridizes to a sequence downstream (3′) of the toehold domain. 2. The method of claim 1 , wherein expression of a plurality of target coding sequences is controlled. 3. The method of claim 2 , wherein the plurality of target coding sequences encode proteins that interact with each other directly or indirectly. 4. The method of claim 1 , wherein the plurality of taRNA are integrated or encoded in the host cell genome. 5. The method of claim 1 , wherein each taRNA is operably linked to an inducible promoter that is different from all the other taRNA in the plurality. 6. The method of claim 1 , wherein each taRNA has a cognate riboregulator in the cell. 7. The method of claim 1 , wherein at least one taRNA activates two or more riboregulators in the cell. 8. A method of controlling gene and/or protein expression in a cell comprising introducing a plurality of riboregulators into a cell, each riboregulator comprises an RNA comprising codon, (i) a single-stranded toehold domain, (ii) a fully or partially double-stranded stem domain comprising an initiation codon, (iii) a loop domain comprising a ribosome binding site, and (iv) a coding domain for a reporter protein or a protein of interest, modulating expression of one or more of a plurality of trans-activating RNA (taRNA) in the cell, wherein expression of a taRNA in the cell results in increased expression of the coding domain, and wherein each taRNA comprises (i) a first domain that hybridizes to the toehold domain of one of the riboregulators in the plurality and that comprises no or minimal secondary structure, and (ii) a second domain that hybridizes to a sequence downstream (3′) of the toehold domain. 9. The method of claim 8 , wherein one or more riboregulators comprise a coding domain for a transcription factor. 10. The method of claim 8 , wherein modulating expression of one or more of a plurality of taRNA comprises increasing expression of a subset of taRNA substantially simultaneously.

Assignees

Inventors

Classifications

  • C12Q1/6897Primary

    involving reporter genes operably linked to promoters · CPC title

  • C12N15/113Primary

    Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; {Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing (when used in plants C12N15/8218)} · CPC title

  • against receptors or cell surface proteins · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US11788156B2 cover?
The invention provides novel and versatile classes of riboregulators, including inter alia activating and repressing riboregulators, switches, and trigger and sink RNA, and methods of their use for detecting RNAs in a sample such as a well and in modulating protein synthesis and expression.
Who is the assignee on this patent?
Harvard College, Univ Boston
What technology area does this patent fall under?
Primary CPC classification C12Q1/6897. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Oct 17 2023 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 6 related publications on this page (citations in our corpus or others sharing the same primary CPC).